Rakesh Uppal comments on London Life Sciences Strategy
By
Thomas.hauschildt1
19d agoen
Source
bartslifesciences.orgRakesh Uppal comments on London Life Sciences Strategybartslifesciences.orgWriting for Healthcare Today, Rakesh Uppal, chief executive of Barts Life Sciences, says that an ambitious life sciences strategy for London demands equally ambitious partnerships. I welcome the publication of London’s Life Sciences Strategy, ambitious, but grounded in where London has fallen short. The strategy rightly identifies the challenge: creating the conditions for the NHS, academia and... The post Rakesh Uppal comments on London Life Sciences Strategy appeared first on Barts Life Sciences .
You might also wanna read
BioPhorum 'subway map' plots route to lights-out biomanufacturing
bioprocessintl.com·8d ago
Huawei’s innovation strategy as old rules stop working
IMD·20d ago
Philips Research leader advocates for curiosity-driven innovation and rapid experimentation
Betsabeh Madani-Hermann, a leader at Philips Research, presented a philosophy for corporate innovation at the Holst Centre Innovation Day fo
ioplus.nl·11d ago
Focus, bold bets, and a bit of fun: How a pharma chief is going for growth
IMD·1d ago
Cambridge Enterprise launches Leaps initiative to embed deeptech startups in London ecosystem
Cambridge Enterprise has launched a new initiative called Leaps, in collaboration with Phoenix Court, Balderton Capital, and the BioInnovati
tech.eu·1mo ago
China's biotech rise: A case study in multiple myeloma drug development
This article examines China's rapid advancement in biotechnology through the lens of a multiple myeloma drug development case study. It disc
writingruxandrabio.com·15d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.